[Pharmacokinetic study of ofloxacin using saliva concentration in chronic renal failure]. 1994

Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
Department of Nephrology, Osaka Prefectural Hospital, Japan.

We evaluated saliva concentration as a parameter of therapeutic drug monitoring (TDM) of Ofloxacin (OFLX) in patients with severe renal failure (CRF). Saliva OFLX concentration correlated closely with serum OFLX concentration as shown in healthy subjects, although it was significantly lower (about three-quarters), indicating that OFLX had less penetration into saliva in patients with renal failure. Saliva concentration was almost equal to serum concentration during hemodialysis, which might have been due to the constant dialysis of OFLX. In conclusion, saliva concentration was useful for TDM of OFLX in patients with CRF, as it is in healthy subjects.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012463 Saliva The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin. Salivas
D015242 Ofloxacin A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. DL-8280,DR-3355,Hoe-280,ORF-28489,Ofloxacin Hydrochloride,Ofloxacine,Ru-43280,Tarivid,DL 8280,DL8280,DR 3355,DR3355,Hoe 280,Hoe280,ORF 28489,ORF28489,Ru 43280,Ru43280
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
October 1998, The Journal of pharmacology and experimental therapeutics,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
January 1989, Clinical therapeutics,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
November 1989, American journal of hypertension,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
November 1991, Clinical pharmacokinetics,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
January 1988, Drugs,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
January 1995, Drugs,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
February 1987, Antimicrobial agents and chemotherapy,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
October 1979, Psychopharmacology bulletin,
Y Tsubakihara, and T Hayashi, and T Shoji, and E Kitamura, and N Okada, and I Nakanishi
January 1987, ASDC journal of dentistry for children,
Copied contents to your clipboard!